NCT05077072Active, not recruitingPhase 2
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
This phase II trial compares different pain management interventions (standard of care \[SOC\], neurofeedback \[NFB\] training, and compassionate high alert team \[CHAT\]) in patients diagnosed with head and neck cancer who are at risk of developing non-medical opioid use (NMOU). The current standard treatment includes regular clinic visits and supportive care and counseling (including topics like patient-doctor communication, cancer care goals, financial issues counseling, and other topics). NFB training is a type of therapy that uses an electroencephalograph (EEG) and a computer software program to measure brain wave activity. The goal of NFB is to help teach patients with pain how to change their own brain waves to lower their feelings of pain and help improve their quality of life. CHAT is a supportive care intervention that includes symptom and pain management, counseling (about pain, symptoms, opioid use and safety, stress, and quality of life), and support for patients and their family members. NFB and CHAT may help to manage pain and lower patient use of opioids.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 22 Sept 2021
- Start date
- 8 Oct 2021
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Head and neck cancer
- NCT number
- NCT05077072
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 28
- From 8 Oct 2021 to the primary completion date, 31 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Employees of MD Anderson Cancer Center
Other
- Individual with clinically evident impaired cognition by Memorial Delirium Assessment Scale (MDAS) score of \>= 13
Who the study is looking for
- Diagnosis of HNC, with patient scheduled to receive radiation therapy, with or without evidence of active disease
- Willingness to be seen in the outpatient supportive care center (SCC)
- History of use of non-medical opioid use (Screener and Opioid Assessment for Patients with Pain \[SOAPP\] \>= 7+ and/or Cut Down, Annoyed, Guilty, and Eye opener questionnaire \[CAGE\] \>= 2+)
- Physician-estimated prognosis of at least 12 months
- Age 18 or older
- Able to complete study assessments
- Willing to sign written informed consent
- Both human papillomavirus (HPV) and non-HPV patients will be included
- Patients currently receiving opioids for at least 1 week
- Able to read, write and speak English
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.